[Erysipelas and necrotizing fasciitis: management (short text). Consensus conference. French Society of Dermatology].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004886:Erysipelas / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D019115:Fasciitis, Necrotizing / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D006760:Hospitalization; D006801:Humans; D006931:Hyperbaric Oxygenation; D011322:Primary Prevention; D011379:Prognosis; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal